DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (AMEX:AXK) announced today that it received notice of allowance on the first patent related to its BACcel® rapid diagnostic platform. The methods enable the BACcel system to quickly identify major multiple drug resistant (MDR) bacteria and their resistance mechanisms. Familiar examples of MDR bacteria, often called “superbugs” by the press, include MRSA (methicillin resistant Staphylococcus aureus), Acinetobacter, and Pseudomonas.
